Вход на сайт

Просмотр новости

Найдите то, что Вас интересует

Elsevier and JAMA Network sign strategic content agreement for ClinicalKey AI

Дата публикации: 12-10-2026 11:02:25


Elsevier, a global leader in advanced information and analytics, today announced a strategic content agreement with the JAMA Network that brings full-text content and visuals from the JAMA Network Family of Journals to ClinicalKey AI, the company’s clinical grade AI workspace. The addition of…
Read more here


Основное содержимое страницы с новостью.

These updates are republished press releases and communications from members of the Science|Business Network


Elsevier, a global leader in advanced information and analytics, today announced a strategic content agreement with the JAMA Network that brings full-text content and visuals from the JAMA Network Family of Journals to ClinicalKey AI, the company’s clinical grade AI workspace. The addition of the JAMA Network’s specialty journals further deepens a content collection that already spans leading journals and medical society publications worldwide, giving clinicians full-text access to more than half of the world’s top 100 medical journals.

Under the agreement, all published full-text content and visuals from 13 journals — including JAMA, JAMA Network Open and 11 specialty journals (JAMA Cardiology, JAMA Dermatology, JAMA Health Forum, JAMA Internal Medicine, JAMA Neurology, JAMA Oncology, JAMA Ophthalmology, JAMA Otolaryngology–Head & Neck Surgery, JAMA Pediatrics, JAMA Psychiatry and JAMA Surgery) — will inform the responses clinicians receive through ClinicalKey AI.

Clinicians face growing volumes of published evidence and reduced time in which to apply clinical insights. ClinicalKey AI is designed to close that gap by grounding every answer in peer-reviewed, evidence-based sources and linking clinicians directly to the full-text articles behind it. 

Omry Bigger, President, Clinical Solutions, Elsevier, said: “Clinicians tell us that trust is the deciding factor in whether they will use AI at the point of care. This strategic content agreement with the JAMA Network means that when a clinician uses ClinicalKey AI, the answer can draw on many years of prestigious evidence-based content from JAMA journals without compromising privacy and security. We look forward to our strong collaboration with the JAMA Network and bringing the best insights and clinical content directly into the hands of clinicians at the point of care.”

Brian Shields, Group Vice President and Publisher of JAMA and the JAMA Network said: “The research published across the JAMA Network is intended to help inform clinical decisions at the bedside, in the clinic and in the exam room, Working with a global information and analytics leader like Elsevier extends the reach of that evidence to clinicians in the moments they need it most, with the full article always a click away so they can see the study, the methods and the context behind any answer.”

Built for health systems

ClinicalKey AI is deployed by health systems that require both credible content, precision AI and enterprise-grade technology. Access to JAMA Network journals and other evidence-based information is delivered securely and compliantly, with capabilities including:

  • API-based integration options, including compatibility with existing workflow tools.
  • Support for HIPAA-compliant use in North America, with privacy and security controls built to help protect patient health information (PHI).
  • A new deep research assistant that allows clinicians to take a deeper dive into clinical topics.
  • Multi-language support and prompt sharing.
  • Coming soon: Following the recent acquisition of WellSheet, ClinicalKey AI will offer deeper integration into hospital systems’ electronic health records to deliver patient context and trusted clinical information to clinicians. 

This article was first published on 7 October by Elsevier.

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Elsevier commits to accelerate AI-driven science across Europe014.4115-10-2026
2UCD launches Ireland’s first university-led AI research institute 012.1115-10-2026
3New AI tool assesses liver cancer treatment success021.1115-10-2026
4Dataminr and Crisis24 Announce Strategic Partnership to Pioneer the Future of AI-Powered Global Risk Management011.5718-03-2026
5Datafine lleva su revolución de inteligencia artificial contextual para eCommerce a Alhambra Venture5712-06-2026
6Singapore: MOH and HSA Launch Refreshed AI in Healthcare Guidelines01031-03-2026
7Nvidia Opens Israel AI Lab Aimed at Faster Drug and Medical Discoveries014.1723-09-2026
8New NSF initiative aims to unlock dataset value for AI-enabled scientific discovery08.1722-07-2026
9BHSN Brings Contract AI to Hancom Office 2024 ‘Hangeul’012.3914-08-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 7.18. Источник: sciencebusiness.net.